… Due to their mode of production, therapeutic mAbs present diverse and heterogeneous glycosylations. Their … release and DMBlabelling, starting from small amounts of mAbs. The results are consistent with the N-glycosylation … what was found by released glycans analysis. Analysis of mAbs subunits, generated by IdeS enzyme digestion, followed …
… Due to their mode of production, therapeutic glycoproteins present complex and heterogeneous glycosylations. … comprehensive workflow is fully applicable to other glycoproteins, such as mAbs, ADCs, and other proteins produced by the recombinant DNA technology, using …